GeneMatrix Inc. (KOSDAQ:109820)
South Korea · Delayed Price · Currency is KRW 1,720.00
-151.00 (-8.07%)
At close: Oct 8, 2026
GeneMatrix Market Cap
GeneMatrix has a market cap or net worth of 35.08 billion as of October 8, 2026. It is the 35,152nd most valuable company in the world and the 2,076th biggest in South Korea. Its market cap has decreased by 35.82% in one year.
Market Cap
35.08B
Enterprise Value
n/a
Revenue
4.72B
Global Rank
Country Rank
#2,076 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 6, 2009, GeneMatrix's market cap has increased from 33.85B to 35.08B, an increase of 3.63%. That is a compound annual growth rate of 0.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 35.08B | -29.94% |
| Dec 30, 2025 | 50.07B | -9.74% |
| Dec 30, 2024 | 55.47B | -12.40% |
| Dec 28, 2023 | 63.32B | -23.43% |
| Dec 29, 2022 | 82.69B | -58.54% |
| Dec 30, 2021 | 199.45B | -62.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 229.34B |
| 3billion | 187.75B |
| GC Medical Science | 89.50B |
| HLB Panagene | 80.77B |
| GENINUS | 76.81B |
| Protia | 76.38B |
| Inventera | 74.96B |
| Cytogen | 67.65B |